The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and …
DB Kell, E Pretorius - Biochemical Journal, 2022 - portlandpress.com
Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …
during the reoxygenation phase following hypoxia, is well known in a variety of acute …
Bacilli as sources of agrobiotechnology: recent advances and future directions
ZT Dame, M Rahman, T Islam - Green Chemistry Letters and …, 2021 - Taylor & Francis
The group bacilli represent the Gram-positive ubiquitous spore-forming bacteria. Their
diversity, versatility and the ability of producing diverse secondary metabolites including …
diversity, versatility and the ability of producing diverse secondary metabolites including …
Purification, physicochemical properties, and statistical optimization of fibrinolytic enzymes especially from fermented foods: a comprehensive review
AMM Ali, SCB Bavisetty - International Journal of Biological …, 2020 - Elsevier
Fibrinolytic enzymes are proteases responsible for cleavage of fibrin mesh in thrombus clots,
which are the primary causative agents in cardiovascular diseases. Developing safe …
which are the primary causative agents in cardiovascular diseases. Developing safe …
Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer's disease by fermented soybean nanonutraceutical
The present study was performed to evaluate the efficacy of nanonutraceuticals (NN) for
attenuation of neurobehavioral and neurochemical abnormalities in Alzheimer's disease …
attenuation of neurobehavioral and neurochemical abnormalities in Alzheimer's disease …
Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer's …
According to the World Health Organization, globally there are around 18 million patients
suffering from Alzheimer's disease (AD), and this number is expected to double by 2025 …
suffering from Alzheimer's disease (AD), and this number is expected to double by 2025 …
Research progress on the utilisation of embedding technology and suitable delivery systems for improving the bioavailability of nattokinase: a review
X Zhou, L Liu, X Zeng - Food Structure, 2021 - Elsevier
Nattokinase is a thrombolytic drug that is more advantageous than urokinase, streptokinase,
and tissue plasminogen activator because of its low price, high efficiency, and nontoxic side …
and tissue plasminogen activator because of its low price, high efficiency, and nontoxic side …
[HTML][HTML] Nattokinase: Insights into Biological Activity, Therapeutic Applications, and the Influence of Microbial Fermentation
M Fang, B Yuan, M Wang, J Liu, Z Wang - Fermentation, 2023 - mdpi.com
Nattokinase, a serine protease that originates from the traditional food natto, has garnered
widespread attention due to its pharmacological functions and therapeutic potential. This …
widespread attention due to its pharmacological functions and therapeutic potential. This …
Automated microscopic measurement of fibrinaloid microclots and their degradation by nattokinase, the main natto protease
Nattokinase, from the Japanese fermented food natto, is a protease with fibrinolytic activity
that can thus degrade conventional blood clots. In some cases, however, including in Long …
that can thus degrade conventional blood clots. In some cases, however, including in Long …
[HTML][HTML] Design of expert guided investigation of native L-asparaginase encapsulated long-acting cross-linker-free poly (lactic-co-glycolic) acid nanoformulation in an …
Present study explores native L-asparaginase encapsulated long-acting cross-linker-free
PLGA-nanoformulation in an Ehrlich ascites tumor model. L-asparaginase-PLGA …
PLGA-nanoformulation in an Ehrlich ascites tumor model. L-asparaginase-PLGA …
Divalent toxoids loaded stable chitosan–glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral …
H Harde, K Siddhapura, AK Agrawal, S Jain - International Journal of …, 2015 - Elsevier
The present study reports dual tetanus and diphtheria toxoids loaded stable chitosan–
glucomannan nanoassemblies (sCh–GM-NAs) formulated using tandem ionic gelation …
glucomannan nanoassemblies (sCh–GM-NAs) formulated using tandem ionic gelation …